U.S. to resume J&J COVID-19 vaccinations despite rare clot risk

The government uncovered 15 vaccine recipients who developed a highly unusual kind of blood clot, out of nearly 8 million people given the J&J shot

from The Hindu - Home https://ift.tt/2QT6N2C
https://ift.tt/2IyLjhI